News
Nuvation Bio (NUVB) wins U.S. FDA approval for its oral antitumor agent Ibtrozi as a treatment for certain patients with ...
14h
Zacks Investment Research on MSNNavitas Semiconductor (NVTS) Soars 10.8%: Is Further Upside Left in the Stock?Navitas Semiconductor Corporation NVTS shares ended the last trading session 10.8% higher at $8.09. The jump came on an impressive volume with a higher-than-average number of shares changing hands in ...
The high- and low-water price targets for Wall Street's artificial intelligence (AI) darling have ignored what's arguably the ...
Novo Nordisk ( NVO 6.12%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky ...
The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...
Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...
2d
Zacks Investment Research on MSNWhy Novartis (NVS) is a Top Momentum Stock for the Long-TermTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service ...
According to the financial investment industry on the 8th, Goldman Sachs lowered its target price for L&F from the previous 80,000 ... the expansion of its own battery cell production, and Northvolt, ...
If Palantir Technologies (NASDAQ: PLTR) and Nvidia (NASDAQ: NVDA) were in the stock equivalent of a boxing match, we'd have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results